Biomea Fusion (BMEA) Stock Insights
BMEA$0.65+0.01 +0.83%
$46.83M
Market Cap
-1.25
P/E
—
Forward P/E
70
Score
Biomea Fusion (BMEA) Stock Insights
BMEA price $0.65 +0.01 +0.83%
- Ticker
- BMEA
- Price
- $0.65
- Change
- +0.01 +0.83%
- Market cap ?
- $46.83M
- P/E ?
- -1.25
- Dividend yield ?
- 0.00%
- Beta ?
- -0.30
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 70
- Value
- 59
- Quality
- 52
- Growth
- 100
Stocklytics score rationale: value 59, quality 52, growth 100.
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It’s lead clinical program’s drug candidates are COVALENT-111 and COVALENT-112, which has completed Phase II clinical trials of icovamenib for the treatment of Type 1 and Type 2 diabetes; COVALENT-211, which is in Phase II clinical trial of…
Fair value
BMEA fair value Not meaningful. Price $0.65.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-03 | — | -0.18 | — | — |
| 2026-08-06 | -0.12 | -0.22 | — | — |
| 2026-05-11 | -0.17 | -0.24 | — | — |
| 2026-03-24 | -0.64 | -0.25 | — | — |
| 2025-11-04 | -0.27 | -0.26 | — | — |
| 2025-08-05 | -0.51 | -0.59 | — | — |
| 2025-05-05 | -0.80 | -0.84 | — | — |
| 2025-03-31 | -0.81 | -1.00 | 1.22M | — |
| 2024-10-29 | -0.91 | -1.05 | — | — |
| 2024-07-31 | -1.03 | -1.03 | — | — |
| 2024-05-02 | -1.09 | -1.02 | — | — |
| 2024-04-01 | -0.98 | -0.85 | 6.14M | — |
| 2023-10-30 | -0.80 | -0.83 | — | — |
| 2023-07-31 | -0.70 | -0.86 | — | — |
| 2023-05-02 | -0.98 | -0.80 | — | — |
| 2023-03-28 | -0.86 | -0.81 | — | — |
| 2022-11-07 | -0.78 | -0.65 | — | — |
| 2022-08-01 | -0.59 | -0.60 | — | — |
| 2022-05-16 | -0.56 | -0.53 | — | — |
| 2022-02-28 | -0.51 | -0.45 | — | — |
| 2021-11-03 | -0.43 | -0.40 | — | — |
| 2021-08-11 | -0.33 | -0.22 | — | — |
| 2021-05-27 | -0.49 | -0.14 | — | — |
| 2021-04-19 | -0.13 | — | — | — |
| 2020-09-30 | -0.11 | — | — | — |
| 2020-06-30 | -0.03 | — | — | — |
| 2020-03-31 | -0.04 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-10 | Faust Elizabeth | Buy | 196.30K | $1.15 | 225.74K |
| 2026-06-10 | AGUIAR ERIC | Buy | 196.30K | $1.15 | 225.74K |
| 2026-06-10 | Ray Sumita | Buy | 196.30K | $1.15 | 225.74K |
| 2026-06-10 | Averill Julianne | Buy | 173.71K | $1.15 | 199.77K |
| 2026-04-01 | Erdtmann Rainer M | Buy | 452.51K | $1.49 | 674.24K |
| 2026-04-01 | Hitchcock Michael J.M. | Buy | 667.48K | $1.49 | 994.54K |
| 2025-12-31 | Erdtmann Rainer M | Other | 0 | — | — |
| 2025-12-31 | Erdtmann Rainer M | Sell | 50.60K | — | — |
| 2025-12-31 | Erdtmann Rainer M | Sell | 50.00K | — | — |
| 2025-12-31 | Erdtmann Rainer M | Sell | 50.00K | — | — |
| 2025-12-31 | Erdtmann Rainer M | Other | 0 | — | — |
| 2025-12-31 | Erdtmann Rainer M | Buy | 50.00K | — | — |
| 2025-12-11 | Erdtmann Rainer M | Buy | 30.00K | $1.43 | 43.00K |
| 2025-12-02 | Hitchcock Michael J.M. | Buy | 100.00K | $0.99 | 99.18K |
| 2025-12-01 | Erdtmann Rainer M | Buy | 10.00K | $1.05 | 10.50K |
| 2025-11-28 | Erdtmann Rainer M | Buy | 40.00K | $1.10 | 44.05K |
| 2025-08-11 | Hitchcock Michael J.M. | Buy | 916.43K | $1.53 | 1.40M |
| 2025-08-11 | Erdtmann Rainer M | Buy | 1.25M | $1.53 | 1.91M |
| 2025-08-01 | Chen Bihua | Other | 0 | — | — |
| 2025-07-22 | Averill Julianne | Buy | 241.18K | $1.82 | 438.94K |
| 2025-07-22 | Averill Julianne | Other | 0 | — | — |
| 2025-06-11 | Faust Elizabeth | Buy | 91.97K | $2.50 | 229.93K |
| 2025-06-11 | AGUIAR ERIC | Buy | 91.97K | $2.50 | 229.93K |
| 2025-06-11 | Ray Sumita | Buy | 91.97K | $2.50 | 229.93K |
| 2025-06-11 | Chen Bihua | Buy | 91.97K | $2.50 | 229.93K |
| 2025-03-26 | Hitchcock Michael J.M. | Buy | 350.00K | $2.52 | 882.00K |
| 2025-01-31 | Erdtmann Rainer M | Sell | 10.00K | — | — |
| 2025-01-31 | Erdtmann Rainer M | Sell | 10.00K | — | — |
| 2025-01-31 | Erdtmann Rainer M | Sell | 10.00K | — | — |
| 2025-01-31 | Erdtmann Rainer M | Buy | 10.00K | — | — |
| 2025-01-31 | Erdtmann Rainer M | Buy | 10.00K | — | — |
| 2025-01-28 | Erdtmann Rainer M | Sell | 40.00K | — | — |
| 2024-11-30 | Valle Franco | Buy | 495 | $6.15 | 3.05K |
| 2024-09-30 | Hitchcock Michael J.M. | Buy | 10.00K | $10.06 | 100.60K |
| 2024-06-12 | Chen Bihua | Buy | 51.02K | $4.63 | 236.25K |
| 2024-06-12 | Ray Sumita | Buy | 51.02K | $4.63 | 236.25K |
| 2024-06-12 | Faust Elizabeth | Buy | 51.02K | $4.63 | 236.25K |
| 2024-06-12 | Hitchcock Michael J.M. | Buy | 51.02K | $4.63 | 236.25K |
| 2024-06-12 | AGUIAR ERIC | Buy | 51.02K | $4.63 | 236.25K |
| 2024-06-11 | Valle Franco | Buy | 12.51K | $4.43 | 55.36K |
| 2024-05-31 | Valle Franco | Buy | 4.45K | $3.78 | 16.82K |
| 2024-05-31 | Frias Juan Pablo | Buy | 349 | $8.94 | 3.12K |
| 2024-01-17 | Butler Thomas Andrew | Buy | 407.50K | $14.44 | 5.88M |
| 2024-01-17 | Erdtmann Rainer M | Buy | 135.70K | $14.44 | 1.96M |
| 2024-01-17 | Valle Franco | Buy | 145.25K | $14.44 | 2.10M |
| 2024-01-17 | Frias Juan Pablo | Buy | 111.09K | $14.44 | 1.60M |
| 2023-12-29 | Erdtmann Rainer M | Sell | 3.00K | — | — |
| 2023-12-29 | Erdtmann Rainer M | Sell | 3.00K | — | — |
| 2023-12-29 | Erdtmann Rainer M | Sell | 3.00K | — | — |
| 2023-12-29 | Erdtmann Rainer M | Sell | 12.00K | — | — |
| 2023-12-29 | Erdtmann Rainer M | Buy | 3.00K | — | — |
| 2023-12-29 | Erdtmann Rainer M | Buy | 3.00K | — | — |
| 2023-11-30 | Valle Franco | Buy | 1.34K | $3.78 | 5.09K |
| 2023-08-31 | Frias Juan Pablo | Buy | 300.00K | $16.87 | 5.06M |
| 2023-08-31 | Frias Juan Pablo | Other | 0 | — | — |
| 2023-06-14 | Hitchcock Michael J.M. | Buy | 6.99K | $38.90 | 271.87K |
| 2023-06-14 | Chen Bihua | Buy | 6.99K | $38.90 | 271.87K |
| 2023-06-14 | Faust Elizabeth | Buy | 6.99K | $38.90 | 271.87K |
| 2023-06-14 | Ray Sumita | Buy | 6.99K | $38.90 | 271.87K |
| 2023-06-14 | AGUIAR ERIC | Buy | 6.99K | $38.90 | 271.87K |
| 2023-06-01 | A2A Pharmaceuticals, Inc. | Sell | 50.00K | $34.56 | 1.73M |
| 2023-05-31 | Valle Franco | Buy | 4.27K | $3.78 | 16.16K |
| 2023-05-31 | A2A Pharmaceuticals, Inc. | Sell | 75.00K | $33.81 | 2.54M |
| 2023-05-12 | A2A Pharmaceuticals, Inc. | Sell | 25.00K | $33.84 | 846.00K |
| 2023-05-09 | A2A Pharmaceuticals, Inc. | Sell | 150.00K | $34.50 | 5.18M |
| 2023-05-08 | A2A Pharmaceuticals, Inc. | Sell | 100.00K | $33.99 | 3.40M |
| 2023-04-20 | A2A Pharmaceuticals, Inc. | Sell | 200.00K | $29.12 | 5.82M |
| 2023-03-31 | A2A Pharmaceuticals, Inc. | Sell | 200.00K | $31.25 | 6.25M |
| 2023-03-31 | A2A Pharmaceuticals, Inc. | Buy | 200.00K | $31.25 | 6.25M |
| 2023-03-30 | Chen Bihua | Buy | 400.00K | $30.00 | 12.00M |
| 2023-01-06 | Erdtmann Rainer M | Buy | 118.00K | — | — |
| 2023-01-06 | Valle Franco | Buy | 126.30K | — | — |
| 2023-01-06 | Butler Thomas Andrew | Buy | 354.35K | — | — |
| 2022-12-31 | Erdtmann Rainer M | Other | 0 | — | — |
| 2022-12-31 | Erdtmann Rainer M | Other | 0 | — | — |
| 2022-12-31 | Erdtmann Rainer M | Other | 0 | — | — |
| 2022-12-31 | Erdtmann Rainer M | Other | 0 | — | — |
| 2022-12-31 | Erdtmann Rainer M | Other | 0 | — | — |
| 2022-12-31 | Erdtmann Rainer M | Other | 0 | — | — |
| 2022-12-31 | Erdtmann Rainer M | Other | 0 | — | — |
| 2022-12-31 | Erdtmann Rainer M | Other | 0 | — | — |
| 2022-12-28 | Erdtmann Rainer M | Sell | 4.00K | — | — |
| 2022-12-28 | Erdtmann Rainer M | Sell | 4.00K | — | — |
| 2022-12-28 | Erdtmann Rainer M | Sell | 4.00K | — | — |
| 2022-12-28 | Erdtmann Rainer M | Sell | 70.00K | — | — |
| 2022-12-28 | Erdtmann Rainer M | Buy | 4.00K | — | — |
| 2022-12-28 | Erdtmann Rainer M | Buy | 4.00K | — | — |
| 2022-11-30 | Valle Franco | Buy | 2.52K | $3.78 | 9.52K |
| 2022-11-14 | Hitchcock Michael J.M. | Buy | 5.00K | $7.93 | 39.65K |
| 2022-11-11 | Valle Franco | Buy | 4.10K | $7.63 | 31.29K |
| 2022-08-19 | Erdtmann Rainer M | Sell | 16.00K | — | — |
| 2022-08-16 | Erdtmann Rainer M | Sell | 17.10K | — | — |
| 2022-08-16 | A2A Pharmaceuticals, Inc. | Sell | 30.68K | $13.87 | 425.65K |
| 2022-07-21 | A2A Pharmaceuticals, Inc. | Sell | 34.66K | $11.21 | 388.52K |
| 2022-07-01 | Erdtmann Rainer M | Sell | 100.00K | — | — |
| 2022-06-24 | A2A Pharmaceuticals, Inc. | Sell | 34.66K | $11.76 | 407.58K |
| 2022-06-22 | Ray Sumita | Buy | 23.87K | $10.20 | 243.44K |
| 2022-06-22 | Ray Sumita | Buy | 23.87K | — | — |
| 2022-06-22 | Hitchcock Michael J.M. | Buy | 23.87K | — | — |
| 2022-06-22 | AGUIAR ERIC | Buy | 23.87K | $10.20 | 243.44K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 65, holders -3 vs prior quarter. Ownership 34.90%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| FMR LLC | 8.81M | 1.59K | +0.02% | 12.96M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.83M | 232.63K | +8.96% | 4.16M |
| MARSHALL WACE, LLP | 2.05M | 851.25K | +71.02% | 3.01M |
| AISLING CAPITAL MANAGEMENT LP | 2.05M | 0 | 0.00% | 3.01M |
| RENAISSANCE TECHNOLOGIES LLC | 1.46M | 142.68K | +10.87% | 2.14M |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | 723.18K | 166.14K | +29.83% | 1.06M |
| BLACKROCK, INC. | 715.45K | 74.01K | +11.54% | 1.05M |
| GEODE CAPITAL MANAGEMENT, LLC | 708.85K | 160.67K | +29.31% | 1.04M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 612.74K | 576.93K | +1611.55% | 900.72K |
| MARINER, LLC | 594.73K | -59.85K | -9.14% | 874.25K |
| JANE STREET GROUP, LLC | 458.29K | 366.69K | +400.32% | 673.68K |
| UBS GROUP AG | 444.73K | 444.73K | New | 653.75K |
| XTX TOPCO LTD | 406.88K | -123.66K | -23.31% | 598.11K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 398.50K | 362.70K | +1013.13% | 585.79K |
| TWO SIGMA INVESTMENTS, LP | 384.46K | -4.24K | -1.09% | 565.15K |
| MORGAN STANLEY | 367.02K | 20.28K | +5.85% | 539.52K |
| VANGUARD FIDUCIARY TRUST CO | 338.35K | 2.23K | +0.66% | 497.37K |
| MAI CAPITAL MANAGEMENT | 289.10K | 200.00K | +224.47% | 424.98K |
| STATE STREET CORP | 257.31K | 49.30K | +23.70% | 378.25K |
| GSA CAPITAL PARTNERS LLP | 216.02K | 186.50K | +631.85% | 318.00K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 215.80K | 180.00K | +502.79% | 317.23K |
| CITADEL ADVISORS LLC | 178.30K | 178.30K | New | 262.10K |
| LMR PARTNERS LLP | 200.00K | 0 | 0.00% | 261.00K |
| NORTHERN TRUST CORP | 128.53K | -80.44K | -38.49% | 188.93K |
| JANE STREET GROUP, LLC | 123.00K | 31.40K | +34.28% | 180.81K |
Insights · Dividends · Forecast · Financials · Learn